KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Retained Earnings (2016 - 2025)

Globus Medical's Retained Earnings history spans 15 years, with the latest figure at $15.3 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 98.67% year-over-year to $15.3 million; the TTM value through Dec 2025 reached $15.3 million, down 98.67%, while the annual FY2025 figure was $15.3 million, 98.67% down from the prior year.
  • Retained Earnings reached $15.3 million in Q4 2025 per GMED's latest filing, down from $1.3 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $1.3 billion in Q3 2023 to a low of -$32.2 million in Q3 2022.
  • Average Retained Earnings over 5 years is $544.1 million, with a median of $12.8 million recorded in 2025.
  • The largest YoY upside for Retained Earnings was 67663.38% in 2022 against a maximum downside of 1513.74% in 2022.
  • A 5-year view of Retained Earnings shows it stood at $1.2 billion in 2021, then rose by 3.82% to $1.2 billion in 2022, then fell by 8.28% to $1.1 billion in 2023, then rose by 1.37% to $1.2 billion in 2024, then crashed by 98.67% to $15.3 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Retained Earnings are $15.3 million (Q4 2025), $1.3 billion (Q3 2025), and $10.2 million (Q2 2025).